Cukierman & Co. Life Sciences

Established in 2006, Cukierman & Co. Life Sciences (CLS) which constitutes CIH’s largest Investment Banking Practice, provides financial advisory services to private and public companies, at different stages of development, across the whole healthcare spectrum, in Israel, Europe, Asia and America with strategic partners. Cukierman & Co. Life Sciences mission is to assist: Biotechnology, pharmaceuticals, diagnostics, medical devices, artificial intelligence and digital health companies in identifying, negotiating and closing equity and venture debts, licensing agreements, strategic partnerships and M&A transactions; We support venture capital & private equity funds, private investors & family offices, corporate funds & corporate development teams, in selecting, evaluating, acquiring and divesting assets, businesses and companies in all life sciences sectors. CLS talented team of scientific, medical, finance and business experts, jointly with our extensive international network, provides corporate guidance and global industry knowledge for fundraising and financial transactions.